irritable bowel syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Persons aged 18-70 years old, regardless of gender; (2) Those who meet the above diagnostic criteria of IBS-D Rome IV; have typical symptoms of IBS-D; (3) The course of the disease exceeds 6 months; (4) The total score of the IBS Severity Scale at the baseline period is =75 points; (5) Patients with mild or moderate depression or anxiety, that is, those with a GAD-7 total score of 5-15, or a PHQ-9 total score of 5-15; (6) Normal cognitive function, good compliance, willing to cooperate with the research, voluntarily participate in this trial and sign the informed consent. Note: Inclusion only if all the above conditions are met.
Exclusion criteria
Exclusion criteria: (1) Those who meet the diagnostic criteria of IBS-C, IBS-M, and IBS-U Rome IV; (2) Those who have been diagnosed with organic diseases of the digestive system in the past, such as inflammatory bowel disease, intestinal tuberculosis, intestinal tumors, etc.; (3) Patients with severe heart, cerebrovascular system, liver, kidney, hematopoietic system, endocrine system, and rheumatic immune system in the past; (4) Severe mental illness and obvious cognitive impairment in the past; (5) Patients who have received acupuncture treatment in the past three months; (6) Pregnant or lactating women; (7) Patients who are participating in other clinical studies. Note: All patients who meet any one of the above items will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VSI;GAD-7;PHQ-9;IBS-QOL;PQSI;EEG;IBS-SSS; | — |
Countries
China